Article

eAbstract: Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing's Syndrome

This study determined that posterior retroperitoneoscopic adrenalectomy is a safe procedure for patients with Cushing's syndrome.

Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s Syndrome

Journal: World Journal of Surgery (February 2010)

Authors: Alesina PF, Hommeltenberg S, Meier B, et al.

Purpose: To examine the safety and efficacy of posterior retroperitoneoscopic adrenalectomy in patients with Cushing’s syndrome.

Results: The mortality rate for the procedures was zero, and no complications occurred. The researchers concluded that “the posterior retroperitoneoscopic approach is fast and safe even in patients with Cushing’s syndrome.”

Click here to access this third-party resource.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.